Last reviewed · How we verify

NCT05570916: ZIMS

Zip-Stitch® in Minimally-Invasive Surgery (ZIMS) - Safety & Efficacy in Hysterectomy

Active, enrolled NA Last updated 18 November 2024
What this trial tests

NA trial testing Zip-stitch(R) in Laparoscopic Hysterectomy in 59 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
17 August 2023
Primary endpoint
12 June 2024
10 May 2025

Quick facts

Lead sponsorZSX Medical LLC
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposetreatment
Enrollment59
Start date17 August 2023
Primary completion12 June 2024
Estimated completion10 May 2025
Sites5 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

ZSX Medical LLC

Who can join

18 and older, female only, with Laparoscopic Hysterectomy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary objective of this study is to evaluate the safety and efficacy of the Zip-stitch® Vaginal Cuff Closure System. This will be primarily done by measuring the frequency of implant passing following system use. Also assessed will be relevant safety and efficacy endpoints as compared to a two-to-one reference group.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Laparoscopic Hysterectomy

Currently open trials in the same condition.

Other ZSX Medical LLC trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05570916.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing